The committee that advises the California Division of Workers' Compensation on evidence-based changes to the prescription drug formulary is meeting on July 15.
Members of the Pharmacy and Therapeutics Committee are scheduled to discuss unique identifiers used for medications that are included on the Medical Treatment Utilization Schedule drug list.
The committee will also discuss GLP-1 medications, proton pump inhibitors, and anticonvulsant and migraine drugs.
The committee is meeting virtually from 12:30-2:30 p.m.
More information, including for accessing the virtual meeti...
Comments